Dr Bill Nelson and Dr Elizabeth Jaffee discuss the creation of Break Through Cancer, a new collaborative partnership between The Johns Hopkins Kimmel Cancer Center, The Dana Farber Cancer Institute, The Koch Institute for Integrative Cancer Research at MIT, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center that will help accelerate research, clinical trials, and new treatments for the most lethal cancers.

To learn more about Break Through Cancer, visit breakthroughcancer.org.

March is Colorectal Cancer Awareness Month and in this Kimmel in DC podcast, Dr Ashwani Rajput speaks with Dr Valerie Lee about the importance of screening as well as the diagnosis and treatment for patients who develop the disease.

Dr Bill Nelson speaks with Mike Armstrong and Eric Vohr about their new book, Cancer with Hope, which chronicles how hope and purpose helped Mike and other cancer patients manage the many challenges associated with this devastating disease.

Learn more about the book here: jhupbooks.press.jhu.edu/title/cancer-hope

Dr Bill Nelson speaks with Dr Lauren Berninger, Dr Pat Carroll and Pharmacist Julie Waldfogel about pain management for patients with cancer at risk for substance abuse. 

Dr Bill Nelson speaks with Paul Goldberg, Editor of the Cancer Letter, and Dr Otis Brawley about the Cancer History Project.

Visit the Cancer History Project website at cancerhistoryproject.com

Dr Ashwani Rajput and Dr Maureen O'Donnell discuss the surgery options for patients diagnosed with breast cancer.

Dr Bill Nelson speaks with Dr J James Frost about his recent paper, 'Cancer's Intelligence,' on how the disease plots its growth in the body to overcome our efforts to stop it.

To read more on Dr Frost's work, click here: eurekalert.org/pub_releases/2020-12/swbc-ci122220.php

Dr Bill Nelson talks to Dina Lansey and Dr Otis Brawley about their work using resources from the state of Maryland's Cigarette Restitution Fund to educate patient populations on the benefits of clinical trials and overcome barriers to participation.

Dr Akila Viswanathan and the COVID-19 response team from the Department of Radiation Oncology and Molecular Radiations Sciences provide an update on our response to the COVID-19 pandemic.